Concepts (114)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Steroid | 5 | 2025 | 26 | 3.320 |
Why?
|
| Antiviral Agents | 4 | 2025 | 112 | 2.250 |
Why?
|
| Virus Replication | 3 | 2025 | 65 | 1.470 |
Why?
|
| Enterovirus | 2 | 2019 | 10 | 1.260 |
Why?
|
| Immunity, Innate | 2 | 2025 | 226 | 0.960 |
Why?
|
| Oxysterols | 1 | 2023 | 3 | 0.830 |
Why?
|
| Hydroxycholesterols | 3 | 2023 | 7 | 0.460 |
Why?
|
| Single-Cell Analysis | 4 | 2019 | 50 | 0.450 |
Why?
|
| Proteomics | 2 | 2024 | 180 | 0.400 |
Why?
|
| Cholestenones | 2 | 2014 | 4 | 0.400 |
Why?
|
| Saponins | 2 | 2014 | 5 | 0.400 |
Why?
|
| Phenazines | 1 | 2011 | 3 | 0.370 |
Why?
|
| Spiro Compounds | 1 | 2011 | 5 | 0.370 |
Why?
|
| Steroids | 1 | 2011 | 54 | 0.360 |
Why?
|
| Oxazoles | 3 | 2007 | 5 | 0.360 |
Why?
|
| Heterocyclic Compounds, 4 or More Rings | 3 | 2007 | 11 | 0.350 |
Why?
|
| Biological Products | 1 | 2011 | 65 | 0.350 |
Why?
|
| Mass Spectrometry | 4 | 2024 | 190 | 0.340 |
Why?
|
| Enzyme Inhibitors | 3 | 2020 | 249 | 0.330 |
Why?
|
| Protein Binding | 2 | 2023 | 657 | 0.320 |
Why?
|
| Humans | 17 | 2025 | 27968 | 0.300 |
Why?
|
| gamma-Glutamyltransferase | 2 | 2020 | 18 | 0.300 |
Why?
|
| HeLa Cells | 4 | 2024 | 208 | 0.250 |
Why?
|
| Antineoplastic Agents | 4 | 2019 | 679 | 0.240 |
Why?
|
| Staurosporine | 1 | 2024 | 10 | 0.240 |
Why?
|
| Structure-Activity Relationship | 2 | 2023 | 208 | 0.240 |
Why?
|
| Electrophoresis, Capillary | 1 | 2024 | 13 | 0.220 |
Why?
|
| Biological Factors | 1 | 2003 | 12 | 0.220 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2024 | 156 | 0.210 |
Why?
|
| Ligands | 1 | 2023 | 176 | 0.200 |
Why?
|
| Neoplasms | 1 | 2011 | 803 | 0.200 |
Why?
|
| HEK293 Cells | 2 | 2019 | 186 | 0.190 |
Why?
|
| Bronchi | 1 | 2021 | 38 | 0.180 |
Why?
|
| Respiratory Mucosa | 1 | 2021 | 51 | 0.180 |
Why?
|
| Dipeptides | 1 | 2020 | 22 | 0.180 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2019 | 604 | 0.170 |
Why?
|
| Aldehyde Oxidoreductases | 1 | 2018 | 10 | 0.150 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2018 | 8 | 0.150 |
Why?
|
| Retinal Dehydrogenase | 1 | 2018 | 10 | 0.150 |
Why?
|
| Viral Proteins | 1 | 2019 | 63 | 0.150 |
Why?
|
| Models, Molecular | 4 | 2020 | 452 | 0.150 |
Why?
|
| Drug Design | 1 | 2018 | 63 | 0.150 |
Why?
|
| Metabolome | 2 | 2019 | 68 | 0.140 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2019 | 113 | 0.140 |
Why?
|
| Cell Line | 1 | 2019 | 695 | 0.140 |
Why?
|
| Animals | 4 | 2025 | 10370 | 0.120 |
Why?
|
| Cell Line, Tumor | 3 | 2019 | 1314 | 0.110 |
Why?
|
| Sphingomyelins | 1 | 2011 | 11 | 0.090 |
Why?
|
| Stilbenes | 1 | 2011 | 90 | 0.090 |
Why?
|
| Signal Transduction | 2 | 2021 | 1433 | 0.090 |
Why?
|
| Molecular Structure | 2 | 2018 | 243 | 0.090 |
Why?
|
| Ornithine-Oxo-Acid Transaminase | 2 | 2007 | 3 | 0.090 |
Why?
|
| Lipid Metabolism | 1 | 2011 | 128 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2011 | 252 | 0.080 |
Why?
|
| K562 Cells | 2 | 2019 | 20 | 0.080 |
Why?
|
| Catalytic Domain | 2 | 2020 | 79 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2011 | 802 | 0.070 |
Why?
|
| Crystallography, X-Ray | 2 | 2020 | 222 | 0.070 |
Why?
|
| Protein Conformation | 2 | 2020 | 257 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2021 | 984 | 0.070 |
Why?
|
| Cell Division | 1 | 2007 | 154 | 0.070 |
Why?
|
| Mitosis | 1 | 2007 | 112 | 0.060 |
Why?
|
| Paclitaxel | 2 | 2019 | 190 | 0.060 |
Why?
|
| Cell Death | 2 | 2021 | 118 | 0.060 |
Why?
|
| Phosphoproteins | 1 | 2024 | 117 | 0.060 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2024 | 101 | 0.060 |
Why?
|
| Proteome | 1 | 2024 | 77 | 0.060 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2024 | 71 | 0.060 |
Why?
|
| Deubiquitinating Enzymes | 1 | 2023 | 6 | 0.050 |
Why?
|
| Molecular Conformation | 1 | 2003 | 67 | 0.050 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2023 | 14 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2024 | 163 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2024 | 574 | 0.050 |
Why?
|
| Cell Cycle Proteins | 1 | 2024 | 187 | 0.050 |
Why?
|
| Escherichia coli | 1 | 2024 | 337 | 0.050 |
Why?
|
| Interferons | 1 | 2021 | 69 | 0.050 |
Why?
|
| Cellular Senescence | 1 | 2021 | 125 | 0.040 |
Why?
|
| Binding Sites | 1 | 2020 | 352 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2021 | 247 | 0.040 |
Why?
|
| Cytokines | 1 | 2021 | 446 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2019 | 51 | 0.040 |
Why?
|
| Chickens | 1 | 2018 | 61 | 0.040 |
Why?
|
| Metabolomics | 1 | 2019 | 85 | 0.040 |
Why?
|
| Kinetics | 1 | 2018 | 544 | 0.030 |
Why?
|
| Inflammation | 1 | 2021 | 629 | 0.030 |
Why?
|
| Apoenzymes | 1 | 2015 | 6 | 0.030 |
Why?
|
| Organophosphonates | 1 | 2015 | 7 | 0.030 |
Why?
|
| Aminobutyrates | 1 | 2015 | 4 | 0.030 |
Why?
|
| Glutamic Acid | 1 | 2015 | 51 | 0.030 |
Why?
|
| Catalysis | 1 | 2015 | 133 | 0.030 |
Why?
|
| Adenosine Diphosphate | 1 | 2014 | 27 | 0.030 |
Why?
|
| Adenosine Monophosphate | 1 | 2014 | 21 | 0.030 |
Why?
|
| Phosphatidylcholines | 1 | 2014 | 45 | 0.030 |
Why?
|
| Male | 2 | 2021 | 13424 | 0.030 |
Why?
|
| Doxorubicin | 1 | 2014 | 77 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2014 | 117 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 412 | 0.030 |
Why?
|
| Aging | 1 | 2021 | 968 | 0.030 |
Why?
|
| Aged | 1 | 2021 | 5383 | 0.020 |
Why?
|
| Antimitotic Agents | 1 | 2007 | 5 | 0.020 |
Why?
|
| Oocytes | 1 | 2007 | 24 | 0.020 |
Why?
|
| Xenopus | 1 | 2007 | 28 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2007 | 60 | 0.020 |
Why?
|
| Tubulin Modulators | 1 | 2007 | 17 | 0.020 |
Why?
|
| Molecular Mimicry | 1 | 2007 | 30 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2007 | 58 | 0.020 |
Why?
|
| Neutropenia | 1 | 2007 | 41 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 2007 | 58 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2007 | 74 | 0.020 |
Why?
|
| Body Weight | 1 | 2007 | 248 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2007 | 198 | 0.020 |
Why?
|
| Female | 1 | 2021 | 15074 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2007 | 2367 | 0.010 |
Why?
|
| Mice | 1 | 2007 | 4621 | 0.010 |
Why?
|